Atlas Trials

Tuberous Sclerosis Complex-associated Refractory Seizures

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Tuberous Sclerosis Complex-associated Refractory Seizures

RecordFirmDate
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures (NCT01713946)Novartis Pharmaceuticals2013-04-29

Track Tuberous Sclerosis Complex-associated Refractory Seizures automatically

Every clearance here is in the API, with alerts when new ones post.